Robert J. DeLuccia, Executive Chairman of Acurx, stated: "This new impressive bile acid and microbiome data compliment and extend our knowledge of ibezapolstat's pharmacologic profile. These ...

Bile acid profiles are altered in several gastrointestinal conditions, including irritable bowel syndrome, Crohn's disease, and several forms of diarrhea, colitis and some bacterial infections. The ...

The data presented indicate a favorable gut bile acid profile which may contribute to ibezapostat's beneficial anti-recurrence effect in patients with C. difficile Infection (CDI) Ibezapolstat ...

Ipsen announces Bylvay data shows sustained improvement in severe itch and serum bile acid levels in patients with PFIC and ALGS: Paris, France Tuesday, November 19, 2024, 11:00 H ...

Data supports the safety profile in the ASSERT clinical trial for Bylvay ... PFIC is a group of rare genetic disorders in ...